2020
DOI: 10.1007/s00256-020-03663-x
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of in-phase and opposed-phase T1W gradient echo and T2W fast spin echo dixon chemical shift imaging for the assessment of non-neoplastic, benign neoplastic and malignant marrow lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 17 publications
0
8
0
Order By: Relevance
“…These can be explained by the fact that benign lesions included in this study are lesions with residual bone marrow fat. The results showed that the sequence used in this study can differentiate marrow-replacing malignant lesions from marrow non-replacing variable benign lesions, including nodular hematopoietic marrows, which are sometimes difficult to distinguish from metastases [16] , [17] , [18] .…”
Section: Discussionmentioning
confidence: 81%
“…These can be explained by the fact that benign lesions included in this study are lesions with residual bone marrow fat. The results showed that the sequence used in this study can differentiate marrow-replacing malignant lesions from marrow non-replacing variable benign lesions, including nodular hematopoietic marrows, which are sometimes difficult to distinguish from metastases [16] , [17] , [18] .…”
Section: Discussionmentioning
confidence: 81%
“…Furthermore, we showed that the same FSE T2w Dixon sequence provided high diagnostic performance in the differentiation of benign and malignant VCFs through quantitative analysis. While very few reports of quantitative analysis of spin echo-based Dixon sequences exist for the characterization of bone marrow lesions, quantitative chemical shift imaging has been previously validated with gradient echo-based sequences, including for the characterization of VCFs [22,23]. In a meta-analysis, Thawait et al found one study showing a sensitivity and specificity of 95% (95% CI: 81, 99) and 89% (95% CI: 81, 93), respectively, with a malignancy threshold of signal drop < 20% [2].…”
Section: Discussionmentioning
confidence: 99%
“…The Dixon technique uses CSI to combat this, able to quantify the amount of fat within a lesion by highlighting the degree of SI drop between IP and OP images. 19 It is generally accepted that a SI drop > 20% at 1.5 T is a reliable cut-off value indicating microscopic fat content, and therefore excluding marrow replacement by a neoplastic process (►Fig. 6).…”
Section: Focal Nodular Marrow Hyperplasiamentioning
confidence: 99%
“…The Dixon sequence, particularly the T2W FSE Dixon sequence that is less susceptible to the presence of medullary sclerosis, should be considered to investigate these cases further, often saving the patient an unnecessary needle biopsy. 19 The described appearances on standard TSE sequences, CSI, and CT (if required) should be sufficient to make a confident imaging diagnosis and avoid unnecessary biopsy. However, in the setting of underlying malignancy, a repeat MRI after 6 months can be performed to confirm a lack of progression or even partial/complete resolution, further supporting FNMH.…”
Section: Focal Nodular Marrow Hyperplasiamentioning
confidence: 99%